Abstract
Background
Whipple disease (WD) is an infection caused by the bacterium Tropheryma whipplei (TW). Few cases have been reported in the USA.
Aims
To report on the demographics, clinical manifestations, diagnostic findings, treatment, and outcomes of TW infection.
Methods
Cases of TW infection diagnosed from 1995 to 2010 were identified in three US referral centers and from 1995 to 2015 in one. Definite classic WD was defined by positive periodic acid-Schiff (PAS) staining and probable WD by specific positive TW polymerase chain reaction (PCR) of intestinal specimens. Localized infections were defined by a positive TW PCR result from samples of other tissues/body fluids.
Results
Among the 33 cases of TW infections, 27 (82%) were male. Median age at diagnosis was 53 years (range 11–75). Diagnosis was supported by a positive TW PCR in 29 (88%) and/or a positive PAS in 16 (48%) patients. Classic WD was the most frequent presentation (n = 18, 55%), with 14 definite and 4 probable cases. Localized infections (n = 15, 45%) affected the central nervous system (n = 7), joints (n = 4), heart (n = 2), eye (n = 1), and skeletal muscle (n = 1). Blood PCR was negative in 9 of 17 (53%) cases at diagnosis. Ceftriaxone intravenously followed by trimethoprim and sulfamethoxazole orally was the most common regimen (n = 23, 70%). Antibiotic therapy resulted in clinical response in 24 (73%).
Conclusions
TW infection can present as intestinal or localized disease. Negative small bowel PAS and PCR do not exclude the diagnosis of TW infection, and blood PCR is insensitive for active infection.
Similar content being viewed by others
References
Paulley JW. Whipple’s disease, intestinal lipodystrophy. Gastroenterologia. 1949;75:32.
Jones FA, Paulley JW. Intestinal lipodystrophy. Whipple’s disease. Lancet. 1949;1:214–217.
Dutly F, Altwegg M. Whipple’s disease and “Tropheryma whippelii”. Clin Microbiol Rev. 2001;14:561–583.
Bai JC, Mazure RM, Vazquez H, et al. Whipple’s disease. Clin Gastroenterol Hepatol. 2004;2:849–860.
Paulley JW. A case of Whipple’s disease (intestinal lipodystrophy). Gastroenterology. 1952;22:128–133.
Chears WC Jr, Ashworth CT. Electron microscopic study of the intestinal mucosa in Whipple’s disease. Demonstration of encapsulated bacilliform bodies in the lesion. Gastroenterology. 1961;41:129–138.
Feurle GE, Volk B, Waldherr R. Cerebral Whipple’s disease with negative jejunal histology. N Engl J Med. 1979;300:907–908.
Wilson KH, Blitchington R, Frothingham R, Wilson JA. Phylogeny of the Whipple’s-disease-associated bacterium. Lancet. 1991;338:474–475.
Dobbins WO 3rd. The diagnosis of Whipple’s disease. N Engl J Med. 1995;332:390–392.
Muller C, Stain C, Burghuber O. Tropheryma whippelii in peripheral blood mononuclear cells and cells of pleural effusion. Lancet. 1993;341:701.
Relman DA, Schmidt TM, MacDermott RP, Falkow S. Identification of the uncultured bacillus of Whipple’s disease. N Engl J Med. 1992;327:293–301.
Elkins C, Shuman TA, Pirolo JS. Cardiac Whipple’s disease without digestive symptoms. Ann Thorac Surg. 1999;67:250–251.
Greub G. A new piece added to the whipple puzzle: Tropheryma Whipplei primary infection with bacteremia and cough. Clin Infect Dis. 2010;51:522–524.
Gabus V, Grenak-Degoumois Z, Jeanneret S, Rakotoarimanana R, Greub G, Genne D. Tropheryma whipplei tricuspid endocarditis: a case report and review of the literature. J Med Case Rep. 2010;4:245.
Ramzan NN, Loftus E Jr, Burgart LJ, et al. Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med. 1997;126:520–527.
Bruhlmann P, Michel BA, Altwegg M. Diagnosis and therapy monitoring of Whipple’s arthritis by polymerase chain reaction. Rheumatology (Oxford). 2000;39:1427–1428.
Fenollar F, Fournier P-E, Robert C, Raoult D. Use of Genome Selected Repeated Sequences Increases the Sensitivity of PCR Detection of Tropheryma whipplei. J Clin Microbiol. 2004;42:401–403.
Keita AK, Bassene H, Tall A, et al. Tropheryma whipplei: a common bacterium in rural Senegal. PLoS Negl Trop Dis. 2011;5:e1403.
Li W, Fenollar F, Rolain JM, et al. Genotyping reveals a wide heterogeneity of Tropheryma whipplei. Microbiology. 2008;154:521–527.
Qin S, Clausen E, Lucht L, et al. Presence of Tropheryma whipplei in different body sites in a cohort of healthy subjects. Am J Respir Criti Care Med. 2016;194:243–245.
Martinetti M, Biagi F, Badulli C, et al. The HLA alleles DRB1*13 and DQB1*06 are associated to Whipple’s disease. Gastroenterology. 2009;136:2289–2294.
Fleming JL, Wiesner RH, Shorter RG. Whipple’s disease: clinical, biochemical, and histopathologic features and assessment of treatment in 29 patients. Mayo Clin Proc. 1988;63:539–551.
Desnues B, Al Moussawi K, Fenollar F. New insights into Whipple’s disease and Tropheryma whipplei infections. Microbes Infect. 2010;12:1102–1110.
Arnold CA, Moreira RK, Lam-Himlin D, De Petris G, Montgomery E. Whipple disease a century after the initial description: increased recognition of unusual presentations, autoimmune comorbidities, and therapy effects. Am J Surg Pathol. 2012;36:1066–1073.
Fenollar F, Puechal X, Raoult D. Whipple’s disease. N Engl J Med. 2007;356:55–66.
Lagier JC, Lepidi H, Raoult D, Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine (Baltimore). 2010;89:337–345.
Fenollar F, Lagier JC, Raoult D. Tropheryma whipplei and Whipple’s disease. J Infect. 2014;69:103–112.
Fenollar F, Raoult D. Whipple’s Disease. Clin Vaccin Immunol. 2001;8:1–8.
Dolmans R, Boel C, Lacle M, Kusters J. Clinical manifestations, treatment, and diagnosis of Tropheryma whipplei infections. Clin Microbiol Rev. 2017;30:529–555.
Morgenegg S, Dutly F, Altwegg M. Cloning and sequencing of a part of the heat shock protein 65 gene (hsp65) of “Tropheryma whippleii” and its use for detection of “T. whippleii” in clinical specimens by PCR. J Clin Microbiol. 2000;38:2248–2253.
Feurle GE, Moos V, Schinnerling K, et al. The immune reconstitution inflammatory syndrome in whipple disease: a cohort study. Ann Intern Med. 2010;153:710–717.
Gunther U, Moos V, Offenmuller G, et al. Gastrointestinal diagnosis of classical whipple disease: clinical, endoscopic, and histophatologic features in 191 patients. Medicine (Baltimore). 2015;94:e714.
Muller SA, Vogt P, Altwegg M, Seebach JD. Deadly Carousel or difficult interpretation of new diagnostic tools for Whipple’s disease: case report and review of the literature. Infection. 2005;33:39–42.
Baisden BL, Lepidi H, Raoult D, Argani P, Yardley JH, Dumler JS. Diagnosis of Whipple disease by immunohistochemical analysis: a sensitive and specific method for the detection of Tropheryma whipplei (the Whipple bacillus) in paraffin-embedded tissue. Am J Clin Pathol. 2002;118:742–748.
Edouard S, Fennolar F, Raoult D. The rise of Tropheryma whipplei: a 12-year retrospective study of PCR diagnoses in our reference center. J Clin Microbiol. 2012;50:3917–3920.
Rolain J-M, Fenollar F, Raoult D. False positive PCR detection of Tropheryma whipplei in the saliva of healthy people. BMC Microbiol. 2007;7:48.
Fenollar F, Laouira S, Lepidi H, Rolain J-M, Raoult D. Value of Tropheryma whipplei quantitative polymerase chain reaction assay for the diagnosis of whipple disease: usefulness of saliva and stool specimens for first-line screening. Clin Infect Dis. 2008;47:659–667.
Compain C, Sacre K, Puéchal X, et al. Central nervous system involvement in Whipple Disease: clinical study of 18 patients and long-term follow-up. Medicine (Baltimore). 2013;92:324–330.
Keinath RD, Merrell DE, Vlietstra R, Dobbins WO 3rd. Antibiotic treatment and relapse in Whipple’s disease. Long-term follow-up of 88 patients. Gastroenterology. 1985;88:1867–1873.
Feurle GE, Marth T. An evaluation of antimicrobial treatment for Whipple’s Disease. Tetracycline versus trimethoprim-sulfamethoxazole. Dig Dis Sci. 1994;39:1642–1648.
Ryser RJ, Locksley RM, Eng SC, Dobbins WO 3rd, Schoenknecht FD, Rubin CE. Reversal of dementia associated with Whipple’s disease by trimethoprim-sulfamethoxazole, drugs that penetrate the blood-brain barrier. Gastroenterology. 1984;86:745–752.
Feurle GE, Junga NS, Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple’s disease. Gastroenterology. 2010;138:478–486. quiz 411–472.
Lagier JC, Fenollar F, Lepidi H, Giorgi R, Million M, Raoult D. Treatment of classic Whipple’s disease: from in vitro results to clinical outcome. J Antimicrob Chemother. 2014;69:219–227.
Emonet S, Wuillemin T, Harbarth S, et al. Relapse of Tropheryma whipplei endocarditis treated by trimethoprim/sulfamethoxazole, cured by hydroxychloroquine plus doxycycline. Int J Infect Dis. 2015;30:17–19.
Fenollar F, Perreal C, Raoult D. Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro. Int J Antimicrob Agents. 2014;43:388–390.
Lagier JC, Fenollar F, Lepidi H, Raoult D. Failure and relapse after treatment with trimethoprim/sulfamethoxazole in classic Whipple’s disease. J Antimicrob Chemother. 2010;65:2005–2012.
Boulos A, Rolain J-M, Raoult D. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrob Agents Chemother. 2004;48:747–752.
Lagier JC, Fenollar F, Lepidi H, Raoult D. Evidence of lifetime susceptibility to Tropheryma whipplei in patients with Whipple’s disease. J Antimicrob Chemother. 2011;66:1188–1189.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Hujoel, I.A., Johnson, D.H., Lebwohl, B. et al. Tropheryma whipplei Infection (Whipple Disease) in the USA. Dig Dis Sci 64, 213–223 (2019). https://doi.org/10.1007/s10620-018-5033-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-018-5033-4